Publications
- Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: A genetic substudy of the PRAGUE-8 trial2010 | First Faculty of Medicine, Third Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Coronary artery perforation during percutaneous intervention2010 | First Faculty of Medicine
- High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial2009 | First Faculty of Medicine, Third Faculty of Medicine
- Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "Paradox"2009 | First Faculty of Medicine, Third Faculty of Medicine
- Percutaneous coronary intervention2009 | First Faculty of Medicine
- Reopening of infarct related artery with percutaneous coronary intervention2009 | First Faculty of Medicine
- Treatment of patients after percutaneous coronary intervention2009 | First Faculty of Medicine
- Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-82008 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- How does the time to treatment effect the long term prognosis of patients with acute myocardial infarction treated with PTCA? +1Publication without faculty affiliation
Loading network view...
